Research

High-dimensional characterization of post-acute sequalae of COVID-19

For May 2021, we have selected: Rentsch CT et al. Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study. BMJ 202;372:n311. doi: 10.1136/bmj.n311.

For May 2021, we have selected: Walgaard et al. Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial. Lancet Neurol 2021; 20=:275-283. doi: 10.1016/S1474-4422(20)30494-4.

The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study

Impact of the COVID‐19 pandemic on stroke teleconsultations in Germany in the first half of 2020

Impact of the COVID‐19 pandemic and a national lockdown on hospitalisation for stroke and related 30‐day mortality in France: a nationwide observational study

Outcomes and risk factors associated with SARS-CoV-2 infection in a north American registry of patients with multiple sclerosis

Acute transverse myelitis with dysautonomia following SARS-CoV-2 infection: a case report and review of literature

Neurological outcome and quality of life three months after COVID-19: a prospective observational cohort study

Impact of SARS-CoV-2 on reperfusion therapies for acute ischemic stroke in Lombardy, Italy: the STROKOVID network

Brain and lung imaging correlation in patients with COVID-19: could the severity of lung disease reflect the prevalence of acute abnormalities on neuroimaging? a global multicenter observational Study

Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosis

Vaccinations in multiple sclerosis patients receiving disease-modifying drugs

Is the Frontal Lobe the Primary Target of SARS-CoV-2 ?

Acute ischemic stroke in patients with COVID-19: an analysis from Get With The Guidelines-Stroke